Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy

被引：28
作者：
Alberto Henriquez-Hernandez, Luis [1 ,3 ]
Murias-Rosales, Adolfo [2 ,3 ]
Gonzalez-Hernandez, Ana [3 ,4 ]
Cabrera de Leon, Antonio [3 ,4 ]
Diaz-Chico, Nicolas [3 ,5 ]
Fernandez-Perez, Leandro [1 ,3 ]
机构：
[1] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria 35016, Spain
[2] Hosp Univ Insular Gran Canaria, Med Oncol Serv, Las Palmas Gran Canaria 35016, Spain
[3] ICIC, Madrid, Spain
[4] Hosp La Candelaria, Hosp Univ La Candelaria, Res Unit, Santa Cruz De Tenerife 38010, Spain
[5] Univ Las Palmas Gran Canaria, Physiol Biochem & Mol Biol Dept, Las Palmas Gran Canaria 35016, Spain
来源：
CANCER EPIDEMIOLOGY | 2010年 / 34卷 / 05期
关键词：
Breast cancer; Neoadjuvant chemotherapy; Toxicity; Adverse reaction; Polymorphism; MTHFR; p53; ACUTE LYMPHOBLASTIC-LEUKEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; THYMIDYLATE SYNTHASE; OVARIAN-CANCER; TOXICITY; PHARMACOGENOMICS; THERAPY; RESISTANCE; VARIANTS; RISK;
D O I：
10.1016/j.canep.2010.06.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy. Results Observed allelic frequencies were: TSER, (2) 0.54 and (3) 0.46; MTHFR C677T, (C) 0.59 and (T) 0.41; p53 Arg72Pro, (Arg) 0.73 and (Pro) 0.27; MDR1 C3435T, (C) 0.52 and (T) 0.48. MTHFR allele T and p53 allele Pro were strongly associated with toxicity due to chemotherapy (odds ratio, 7.1 (95% confidence interval, 1.4-36.1; p = 0.018) and 7.0 (95% confidence interval, 1.2-40.5; p = 0.029), respectively). Conclusion We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：634 / 638
页数：5
相关论文
共 45 条
  • [1] MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer
    Afzal, S.
    Jensen, S. A.
    Vainer, B.
    Vogel, U.
    Matsen, J. P.
    Sorensen, J. B.
    Andersen, P. K.
    Poulsen, H. E.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (10) : 1660 - 1666
  • [2] Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation
    Akoglu, B.
    Kindl, P.
    Weber, N.
    Trojan, J.
    Caspary, W. F.
    Faust, D.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (03) : 430 - 435
  • [3] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [4] Limits to Thymidylate Synthase and TP53 Genes as Predictive Determinants for Fluoropyrimidine Sensitivity and Further Evidence for RNA-Based Toxicity as a Major Influence
    Brody, Jonathan R.
    Hucl, Tomas
    Costantino, Christina L.
    Eshleman, James R.
    Gallmeier, Eike
    Zhu, Heng
    van der Heijden, Michiel S.
    Winter, Jordan M.
    Wikiewicz, Agnieszka K.
    Yeo, Charles J.
    Kern, Scott E.
    [J]. CANCER RESEARCH, 2009, 69 (03) : 984 - 991
  • [5] Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    Chua, W.
    Goldstein, D.
    Lee, C. K.
    Dhillon, H.
    Michael, M.
    Mitchell, P.
    Clarke, S. J.
    Iacopetta, B.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 998 - 1004
  • [6] Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India
    De Chaudhuri, Sujata
    Mahata, Julie
    Das, Jayanta K.
    Mukherjee, Angshuman
    Ghosh, Papiya
    Sau, Tanmoy Jyoti
    Mondal, Lakshmikanta
    Basu, Santanu
    Giri, Ashok K.
    Roychoudhury, Susanta
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 601 (1-2) : 102 - 112
  • [7] Presentation of the "CDC de Canarias" Cohort: Objectives, Design and Preliminary Results
    de Leon, Antonio Cabrera
    Rodriguez Perez, M. del Cristo
    Gonzalez, Delia Almeida
    Coello, Santiago Dominguez
    Jaime, Armando Aguirre
    Diaz, Buenaventura Brito
    Hernandez, Ana Gonzalez
    Mendez, Lina I. Perez
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2008, 82 (05): : 519 - 534
  • [8] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
    Dumont, P
    Leu, JIJ
    Della Pietra, AC
    George, DL
    Murphy, M
    [J]. NATURE GENETICS, 2003, 33 (03) : 357 - 365
  • [9] Methylenetetrahydrofolate reductase (MTHFR) variants and fluorouracil-based treatments in colorectal cancer
    Etienne-Grimaldi, Marie-Christine
    Francoual, Mireille
    Formento, Jean-Louis
    Milano, Gerard
    [J]. PHARMACOGENOMICS, 2007, 8 (11) : 1561 - 1566
  • [10] Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
    Fisher, B
    Brown, A
    Mamounas, E
    Wieand, S
    Robidoux, A
    Margolese, RG
    Cruz, AB
    Fisher, ER
    Wickerham, DL
    Wolmark, N
    DeCillis, A
    Hoehn, JL
    Lees, AW
    Dimitrov, NV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2483 - 2493
12345